2m 2m 2m 2m 2m 2m 2m
PRELUDE THERAP (PRLD)
NASDAQ
$3.45-$0.07 (-1.96%)
Price as of Nov 13, 2026 1:55 PM EST- $229.1MMarket Cap
- 133.11%1-Year Change
- BiotechnologyIndustry
PRELUDE THERAP (PRLD)
$3.45-$0.07 (-1.96%)
Earnings Score
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -43.63% | ||
12-Month Momentum | 119.73% | ||
3-Month Risk Adjusted Momentum | -142.22% | ||
12-Month Risk Adjusted Momentum | 112.22% |
True Yield
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |